Electrode system for measuring an analyte concentration under in-vivo conditions
US-2016296151-A1 · Oct 13, 2016 · US
US12042275B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12042275-B2 |
| Application number | US-202117230149-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 14, 2021 |
| Priority date | Dec 9, 2010 |
| Publication date | Jul 23, 2024 |
| Grant date | Jul 23, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes an array two or more discontiguous sensing elements deposited on a substrate surface, where the sensing elements comprise one or more droplets of a sensing element formulation.
Opening claim text (preview).
What is claimed is: 1. A method of manufacturing an analyte sensor comprising: depositing a first array of discontiguous sensing elements on a sensing surface of a working electrode; depositing a second array of discontiguous sensing elements on the sensing surface of the working electrode, each sensing element of the second array being substantially aligned with an interfeature area between the sensing elements of the first array; and forming a membrane over the first and second array of discontiguous sensing elements; wherein the depositing comprises deposition of one or more droplets of a sensing element formulation. 2. The method of claim 1 , wherein the depositing is performed by a non-impact printing method. 3. The method of claim 2 , wherein the non-impact printing method comprises a piezoelectric pulse-jet deposition. 4. The method of claim 2 , wherein the non-impact printing method comprises a thermoelectric pulse-jet deposition. 5. The method of claim 1 , wherein the depositing is performed by an impact printing method. 6. The method of claim 2 , wherein a droplet deposited during a single activation event of the non-impact printing method has a volume ranging from 0.01 pL to 1000 pL. 7. The method of claim 1 , wherein the first array contains a plurality of rows of discontiguous sensing elements, each row being substantially aligned with adjacent rows. 8. The method of claim 1 , wherein the first array contains a plurality of rows of discontiguous sensing elements, each row being offset from adjacent rows. 9. The method of claim 1 , wherein the sensing element formulation comprises an analyte-responsive enzyme. 10. The method of claim 9 , wherein the analyte-responsive enzyme comprises a glucose-responsive enzyme. 11. The method of claim 10 , wherein the glucose-responsive enzyme comprises one or more of a glucose oxidase, a glucose dehydrogenase, a pyrroloquinoline quinone, a dependent glucose dehydrogenase, a flavine adenine dinucleotide dependent glucose dehydrogenase, or a nicotinamide adenine dinucleotide dependent glucose dehydrogenase. 12. The method of claim 10 , wherein the analyte-responsive enzyme comprises a lactate-responsive enzyme. 13. The method of claim 10 , wherein the analyte-responsive enzyme comprises an oxygen-responsive enzyme. 14. The method of claim 1 , wherein the analyte sensor is configured to monitor glucose. 15. The method of claim 1 , wherein the analyte sensor is configured to monitor ketones. 16. The method of claim 1 , wherein the analyte sensor is configured to monitor one or more of acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, glycosylated hemoglobin (HbA1c), creatine kinase (e.g., CK-MB), creatine, creatinine, DNA, fructosamine, glucose, glucose derivatives, glutamine, growth hormones, hormones, ketones, ketone bodies, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. 17. The method of claim 1 , wherein the sensing elements have an average diameter ranging from 0.1 μm to 500 μm. 18. The method of claim 1 , wherein the one or more droplets of the sensing element formulation have a volume ranging from 0.01 pL to 1000 pL. 19. The method of claim 1 , wherein the first array comprises a number of discontiguous sensing elements in a range of 2 to 1000 discontiguous sensing elements. 20. The method of claim 1 , further comprising forming a membrane over the first and second array of discontiguous sensing elements by dipping a portion of the analyte sensor into a membrane solution, wherein the membrane limits flux of analyte to the sensing elements. 21. The method of claim 1 , further comprising forming a membrane over the first and second array of discontiguous sensing elements by spraying a portion of the analyte sensor with a membrane solution, wherein the membrane limits flux of analyte to the sensing elements. 22. The method of claim 1 , wherein the first array of discontiguous sensing elements comprises an inter-feature distance between each of the discontiguous sensing elements ranging from 1 μm to 500 μm. 23. The method of claim 1 , wherein the first array of sensing elements and the second array of sensing elements comprise a different sensing element formulation.
for glucose · CPC title
Enzyme electrodes · CPC title
invasive, e.g. introduced into the body by a catheter · CPC title
using enzyme electrodes, e.g. with immobilised oxidase · CPC title
for measuring glucose, e.g. by tissue impedance measurement · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.